Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Yukie Yoshii"'
Autor:
Chika Igarashi, Hiroki Matsumoto, Masashi Takahashi, Fukiko Hihara, Tomoko Tachibana, Ming-Rong Zhang, Hiroaki Kurihara, Tatsuya Higashi, Yukie Yoshii
Publikováno v:
Nuclear Medicine and Biology. :10-15
Autor:
Daniel P. Cahill, Kensuke Tateishi, Hiroyuki Mano, Shoji Yamanaka, Alexandria Fink, Koichi Ichimura, Takashi Yamamoto, Andrew S. Chi, Makoto Ohtake, Shilpa S. Tummala, Motoo Nagane, Tracy T. Batchelor, Masahito Kawazu, Akio Miyake, Ryohei Miyazaki, Akihide Ryo, Naoko Udaka, Nobuyoshi Sasaki, Manabu Natsumeda, Hidetoshi Murata, Jun Suenaga, Kentaro Ohki, Toshihide Ueno, Yukie Yoshii, Hiroaki Wakimoto, Ichio Aoki, Mayuko Nishi, Jun Watanabe, Taishi Nakamura, Yukihiko Fujii, Yohei Miyake, Jo Sasame, Norio Shiba, Julie J. Miller, Naoki Ikegaya, Yuko Matsushita
Publikováno v:
Cancer Research. 80:5330-5343
Primary central nervous system lymphoma (PCNSL) is an isolated type of lymphoma of the central nervous system and has a dismal prognosis despite intensive chemotherapy. Recent genomic analyses have identified highly recurrent mutations of MYD88 and C
Autor:
Hiroki Matsumoto, Hisashi Suzuki, Ming-Rong Zhang, Kazunori Kawamura, Emi Kaneko, Hiroaki Kurihara, Hiroki Hashimoto, Atsumi Baden, Yukie Yoshii, Tatsuya Higashi
Publikováno v:
Translational Oncology, Vol 12, Iss 9, Pp 1206-1212 (2019)
Translational Oncology
Translational Oncology
Hypoxia plays important roles in the prognosis of malignant brain tumors such as glioblastoma because it causes drug delivery deficiencies and the induction of hypoxia-inducible factor-1α in tumor cells. Extensive hypoxic areas are associated with p
Autor:
Hiroki Matsumoto, Ming-Rong Zhang, Tomoko Tachibana, AtsushiB Tsuji, Yukie Yoshii, Chika Igarashi, Fukiko Hihara, Aya Sugyo, Tatsuya Higashi, Kotaro Nagatsu
Publikováno v:
Journal of Cancer Research and Therapeutics. 18:907
Autor:
Hiroki Matsumoto, Yasuhisa Fujibayashi, Yukie Yoshii, Takako Furukawa, Tsuneo Saga, Mitsuyoshi Yoshimoto
Publikováno v:
Make Life Visible ISBN: 9789811379079
Hypoxia in tumors is known to contribute to the malignant characteristics such as therapy resistance and metastatic potential. Cu-diacetyl-bis (N4-methylthiosemicarbazone) (Cu-ATSM), labeled with several Cu radioisotopes (60Cu, 62Cu and 64Cu) is a po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2617eea3a7c4d0d3e33b1f0da9987a26
https://doi.org/10.1007/978-981-13-7908-6_29
https://doi.org/10.1007/978-981-13-7908-6_29
Autor:
Zhao-Hui Jin, Ming-Rong Zhang, Mitsuyoshi Yoshimoto, Yoko Oe, Hiroki Matsumoto, Hiroaki Kurihara, Atsushi B. Tsuji, Keiichiro Yoshinaga, Yukie Yoshii, Yasuhisa Fujibayashi, Tatsuya Higashi, Yoshitaka Narita
Publikováno v:
Translational Oncology, Vol 11, Iss 1, Pp 24-30 (2018)
Glioblastoma is the most aggressive malignant brain tumor in humans and is difficult to cure using current treatment options. Hypoxic regions are frequently found in glioblastoma, and increased levels of hypoxia are associated with poor clinical outc
Autor:
Yohei Miyake, Taishi Nakamura, Jo Sasame, Koichi Ichimura, Takashi Yamamoto, Hiroaki Wakimoto, Kensuke Tateishi, Yukie Yoshii, Nobuyoshi Sasaki, Motoo Nagane, Masahito Kawazu
Publikováno v:
Neuro-oncology Advances
Primary central nervous system lymphoma (PCNSL) is a rare lymphoma of the central nervous system and has a dismal prognosis despite intensive chemotherapy. Recent genomic analyses have identified recurrent genetic alterations in Primary central nervo
Autor:
Hironori Aoyama, Hidekatsu Wakizaka, Takako Furukawa, Yasuhisa Fujibayashi, Tsuneo Saga, Ming-Rong Zhang, Naoya Adachi, Yukie Yoshii
Publikováno v:
International Journal of Oncology. 48:1477-1484
Colon cancer is one of the leading causes of cancer death worldwide. Adjuvant chemotherapy following primary surgical treatment is suggested to be beneficial in eradicating invisible disseminated small tumors in colon cancer; however, an effective dr
Autor:
Yohei Miyake, Hiroaki Wakimoto, Jo Sasame, Yukie Yoshii, Kensuke Tateishi, Yuko Matsushita, Nobuyoshi Sasaki, Masahito Kawazu, Shoji Yamanaka, Taishi Nakamura, Motoo Nagane, Koichi Ichimura, Takashi Yamamoto, Shigeta Miyake
Publikováno v:
Neuro-oncology Advances
Recent genomic analyses have identified highly recurrent genetic alterations in PCNSL. However, due to the lack of clinically representative PCNSL preclinical models, the pathogenic mechanisms of these alterations remains largely unknown. Here, we es
Autor:
Tatsuya Higashi, Yukie Yoshii, Zhao-Hui Jin, Kotaro Nagatsu, Aya Sugyo, Atsushi B. Tsuji, Mélissa Degardin, Yasuhisa Fujibayashi, Didier Boturyn, Pascal Dumy, Ming-Rong Zhang
Publikováno v:
EJNMMI Research
EJNMMI Research, SpringerOpen, 2018, 8 (1), ⟨10.1186/s13550-018-0407-3⟩
EJNMMI Research, Vol 8, Iss 1, Pp 1-10 (2018)
EJNMMI Research, SpringerOpen, 2018, 8 (1), ⟨10.1186/s13550-018-0407-3⟩
EJNMMI Research, Vol 8, Iss 1, Pp 1-10 (2018)
Background The present study proposed a new concept for targeted radionuclide therapy (TRT) to improve the intratumoral distribution of radioactivity using two different radiopharmaceuticals. We examined the efficacy of a combination of a tetrameric